Recent Headlines
Polar Lab Projects Redefines Laboratory Relocation Standards with Global, Single-Source Logistics Solution
Polar Lab Projects is setting a new standard in laboratory relocations and logistics, offering a single-source, seamless solution tailored to the life sciences industry worldwide. With an extensive network of industry experts, they provide unmatched service excellence, meeting clients' needs wherever they operate. - November 06, 2024 - Polar Lab Projects LLC
VitaMist® New Wholesale Purchasing Service
New Wholesale Business Offering is Geared for Distributors and Retailers - November 02, 2024 - VitaMist
VITAMIST® Launches New MultiPlus Multivitamin Oral Spray
Multi-Vitamin Plus Oral Spray is a Comprehensive Blend of Essential Nutrients - November 02, 2024 - VitaMist
Novugen Pharma Malaysia Achieves Zero Form 483 Citations in Recent USFDA Audit
Novugen Pharma Sdn. Bhd. proudly announces the successful completion of recent USFDA audit, achieving zero Form 483 citations and No Action Indicated (NAI) status—the highest level of compliance for USFDA-registered manufacturing facilities. This milestone positions Novugen among a select few global companies meeting these standards and reflects the dedication of its team. - October 29, 2024 - Novugen
Bloom Lab Launches The Menopause Playbook on World Menopause Day
In honour of World Menopause Day, Bloom Lab is launching The Menopause Playbook, a no-nonsense guide for today's forward-thinking woman with everything she needs to know to tackle menopause like a pro without having to sift through endless books, articles or studies. Created by Kristina von... - October 20, 2024 - Bloom Lab
Nebula Scientific Announces Private Label Service
New Private White Label Service for Oral Spray Vitamins and Supplements - October 19, 2024 - VitaMist
Parvus Announces First Human Subject Dosed in a Clinical Trial with PVT201, a First-in-Class Off-the-Shelf Regulatory T-cell (Treg) Inducing pMHC Nanomedicine Therapy
Parvus Therapeutics, a private clinical-stage biopharmaceutical company developing a pipeline of novel treatments for autoimmune disease announced the successful dosing of the first subject in a Phase 1/2, first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PVT201 single ascending doses in healthy subjects and primary biliary cholangitis patients. - October 17, 2024 - Parvus Therapeutics U.S., Inc.
Aker BioMarine Launches New Website Dedicated to Krill Oil Science and Education
KrillOil.com, a new consumer website for all things related to krill oil, is launching today. - October 06, 2024 - Aker BioMarine
CURE Pharmaceutical Appoints Raymond Watt to Board of Directors
CURE Pharmaceutical, renowned for its innovative sublingual delivery systems, is proud to announce the appointment of Raymond Watt to its Board of Directors. - October 01, 2024 - CURE Pharmaceutical, Inc.
BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter for BUHLMANN fCAL® turbo and fPELA® turbo Assays
BÜHLMANN Laboratories AG, a leading manufacturer of specialty, high-quality in-vitro diagnostic and research assays, is pleased to announce the collaboration with Beckman Coulter for a worldwide distribution of the BÜHLMANN fCAL® turbo assay & BÜHLMANN fPELA® turbo assay... - September 26, 2024 - BUHLMANN Diagnostics Corp
Canaritech Announces the Launch of Operations, Offering Comprehensive Clinical Trial Solutions Across Latin America
Canaritech, a Contract Research Organization (CRO), has officially launched operations across Latin America, with offices in Mexico, Peru, Chile, and Colombia. The company offers a range of clinical trial services, including regulatory consulting, trial management, decentralized clinical trials, and post-market studies. Canaritech aims to drive innovation in clinical research by improving trial efficiency and increasing patient access through localized expertise and advanced technologies. - September 22, 2024 - Canaritech
Sama Therapeutics and Quine Biologics Announce Collaboration to Develop Breakthrough Antibody Therapeutics for Neurological Disorders
Sama Therapeutics and Quine Biologics have partnered to develop an innovative therapy for neurological disorders, combining AI-driven platforms and advanced antibody engineering. The collaboration focuses on biologics that precisely target the central nervous system, minimizing side effects. By integrating Sama's generative AI with Quine's antibody design expertise, the project addresses unmet medical needs and advances treatments for conditions like Alzheimer’s and multiple sclerosis. - September 13, 2024 - Quine Biologics, Inc.
Microvascular Therapeutics Announce Completion of Phase 2 Study Enrollment for MVT-100
Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased to announce the completion of enrollment in MVT’s Phase 2 program using its microbubble product, MVT-100, for endocardial border delineation. This study, An Ascending Dose Comparison of... - September 13, 2024 - Microvascular Therapeutics, Inc.
MEDraysintell and NucAdvisor Join Forces to Expand Their Activities in Nuclear Medicine Consulting Services
MEDraysintell and NucAdvisor, an independent nuclear consulting company, subsidiary of Soletanche Freyssinet (VINCI Group), France, today announced the integration of the MEDraysintell business into NucAdvisor, including the brand and copyright assets. NucAdvisor will now assume responsibility for... - September 06, 2024 - MEDraysintell
Huntington Study Group and HD Genetics Collaborate to Better Serve HD Gene Positive Patients
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce a strategic partnership with HD Genetics to assist patients who have tested positive for Huntington’s disease (HD) learn about and enroll in research studies. There remains a... - September 05, 2024 - Huntington Study Group
I Holland Launch Tool Room Layout Service
I Holland, a world leader in tablet tooling design and manufacturing, is thrilled to announce the launch of its new, bespoke tool room design service. - August 31, 2024 - I Holland Ltd.
Right Enroll Introduces Comprehensive Medicare Plan Comparison & Selection Platform
Empowering Users to Make Informed Medicare Choices with Ease Right Enroll is happy to announce the launch of new Medicare Plan Comparison & Selection System which is aimed to help a client to find out how to choose the right Medicare plan according to his or her needs and peculiarities. Being... - August 24, 2024 - Right Enroll
Official CelluCare Product Launch: Don’t Fall for Fake Websites
CelluCare, a leader in natural health supplements, announces the official launch of its newest product - a natural supplement designed to support healthy blood sugar levels. With increasing demand, concerns about counterfeit products being sold online have also risen. CelluCare advises consumers to purchase exclusively from the official website to ensure product authenticity and secure transactions, backed by a 60-day money-back guarantee. - August 21, 2024 - CelluCare
Huntington Study Group Announces New CEO
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce that Daniel Claassen, MD, MS, an internationally recognized Huntington’s Disease neurologist and researcher has accepted the role as the organization’s Chief Executive... - August 20, 2024 - Huntington Study Group
VitaMist® Announces Exciting Competition: Win a Year’s Supply of Vitamins for You and a Friend
VitaMist®, a leader in Oral Spray Vitamins and Supplements, is thrilled to announce an exciting new competition offering participants the chance to win a year’s supply of vitamins for both themselves and a friend. - August 16, 2024 - VitaMist
Californians Reject Board of Pharmacy’s Proposed Restrictions on Essential Alternative Medicines
Californians fight back against the Board of Pharmacy's proposed regulations that would severely restrict – and in many cases end – access to widely used sterile compounds like methylcobalamin (vitamin B12), glutathione, and NAD, easily accessible and legal in all 49 other United States. The Stop The BOP movement was formed in response, rallying significant public support to preserve access to these essential treatments. - August 08, 2024 - Stop The BOP
Parvus Therapeutics Announces Leadership Appointments to Support Development from Preclinical Into Clinical
New Positions Enhance Parvus Capability to Execute the Translation of Multiple Drug Candidates into the Clinic. - August 06, 2024 - Parvus Therapeutics U.S., Inc.
Minus K Technology Announces Its Ninth Educational Giveaway of Vibration Isolators to U.S. Colleges and Universities
Minus K Technology announces its Educational Giveaway of Vibrations Isolators to U.S. Colleges and Universities. - August 05, 2024 - Minus K Technology Inc.
Silver Scott Mines, Inc. Signs Letter of Intent to Acquire Innovative, Patented Non-Invasive Brain Treatment Technology
Silver Scott Mines will be acquiring the assets of AddBrain, Inc.’s technology. It has been used to treat Huntington’s Disease, Parkinson’s and Suicidal Depression with excellent results. There are ongoing clinical trials in Canada. - August 02, 2024 - Silver Scott Mines, Inc.
GENINVO, a Leading Provider of Innovations in Life Science Announced the Offering of Its On-Demand Service/Tool: DocQC
GENINVO has been working towards automating healthcare industry and contributing to faster drug discovery. GENINVO target to bring innovations as technologies, to automate the traditional and time-consuming process of Medical Writing. One example being, automating the process of clinical and... - August 02, 2024 - GenInvo, Inc.
New Study Explores Potential Benefits of Biophoton Generators in Alzheimer's Care
Study results shared at Alzheimer's Association International Conference in Philadelphia. - July 30, 2024 - Tesla BioHealing, Inc.
Parvus Therapeutics Has Received Orphan Drug Designation for Primary Biliary Cholangitis and Human Research Ethics Committee Approval to Begin Clinical Testing
Parvus Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to PVT201 for the treatment of Primary Biliary Cholangitis (PBC) and PVT201 has obtained Australian Human Research Ethics Committee (HREC) approval to initiate a first-in-human... - July 29, 2024 - Parvus Therapeutics U.S., Inc.
Clinical Studies Highlight the Potential of Tesla BioHealing Biophoton Generator in Improving Mobility for Chronic Stroke Patients
Clinical studies indicate that the Tesla BioHealing® Biophoton Generator may help enhance mobility in patients with chronic stroke conditions. - July 24, 2024 - Tesla BioHealing, Inc.
Leap Years®: Supports Age-Related Cognitive Decline in Dogs and Quality Time Together with Owners Through NAD+ Enrichment
Animal Biosciences Announces Peer-Reviewed Publication of a Clinical Trial to Evaluate the Slowing of Age-Related Signs in Dogs. After five years of development, clinical results are published regarding senior dog aging in a rigorous, placebo-controlled trial performed at a North Carolina State University College of Veterinary Medicine. - July 23, 2024 - Leap Years
U.S. Precision Medicine, Inc. Signs MOU to Deploy microNeb’s VIGIL Series Inhaler Technology to Enhance Absorption of Its New Drug Candidate in IND Process
U.S. Precision Medicine, Inc. (USPM) has signed a Memorandum of Understanding (MOU) to deploy microNeb's advanced inhaler technology to expedite the uptake of its new cancer drug candidate currently in the Investigational New Drug (IND) process. - July 16, 2024 - microNeb, Inc.
Huntington Study Group Announces Launch of LEAD-HD Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) today announce the release of their newest Patient Reported Outcomes (PRO) study, LEAD-HD. This observational study was developed collaboratively with the University of Rochester Center for Health +... - July 15, 2024 - Huntington Study Group
Tesla BioHealing, Inc. Achieves ISO 13485 QMS Certification
Tesla BioHealing, Inc. manufactures unique wellness devices while using a quality management system recently certified by American Systems Registrar (ASR). - July 01, 2024 - Tesla BioHealing, Inc.
I Holland Launches Tooling Safe Disposal & Recycling Service
I Holland, has launched its new Safe Disposal &Recycling Service. This valuable service is designed to ensure the safe, secure, and environmentally responsible destruction of obsolete or worn-out tooling, enhancing both the integrity and sustainability of pharmaceutical manufacturing. Their... - June 23, 2024 - I Holland Ltd.
VITAMIST® Unveils New Enhanced Website for Premium Vitamin Oral Sprays
VITAMIST®, inventor of vitamin oral sprays, is excited to announce the launch of its newly redesigned website, www.vitamist.com. This significant update underscores VITAMIST's commitment to providing high-quality, science-backed vitamin solutions. - June 13, 2024 - VitaMist
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com. PCRassays.com offers more than 200 qPCR-based assays for infectious diseases, over 50 of... - June 07, 2024 - Cayman Chemical Company
Jusha International and Dextro Imaging Form Strategic Partnership
Jusha International Collaborates with Dextro Imaging Specialists, Revolutionizing Radiology with Lower Costs and Enhanced Quality - May 28, 2024 - Dextro
GENINVO Launches Its Latest Offering – DocWrightAI
GENINVO, a leading provider of life science products and business solutions announced the launch of its new, on-demand service: DocWrightAI. GENINVO understands the various challenges in generating clinical documents. The time taken to draft clinical documents with accuracy and compliance has... - May 18, 2024 - GenInvo, Inc.
Snova's Halal Extract Wins Its Third Consecutive Gold at the Monde Selection
Snova’s Halal Extract has won the gold award for its third consecutive year at the Monde Selection 2024. ・Snova’s Halal Extract is a skincare product manufactured in accordance with Islamic law (Halal). In Islam, certain ingredients and manufacturing processes are prohibited, so... - May 15, 2024 - Snova Co.
Dr. Pompa Explores the Hidden Risks of Root Canals
Dr. Pompa discusses the hidden risks of root canals in his latest health coaching initiative, revealing that often these procedures may carry infections that affect surrounding tissues. Despite meticulous care, root canals inherently possess risks, suggesting that sometimes avoiding the procedure might be safer. This exploration underscores the importance of careful decision-making and consultation in dental health and wellness. - May 10, 2024 - Pompa Program
SeabuckWonders Unveils Functional New Product for Women
Fem-Omega 7 Makes its Debut as Ultimate Supplement for Female Dryness. - May 08, 2024 - SeabuckWonders
Novugen Launches Pazopanib Tablets, 200mg, in the U.S. Following ANDA Approval by USFDA
Novugen has launched Pazopanib tablets, 200mg, in the U.S. after receiving ANDA approval from USFDA on April 23, 2024. This significant milestone demonstrates Novugen's continued growth in the U.S. pharmaceutical market with a complex anticancer drug, the generic equivalent of Votrient, used to treat advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS). - May 07, 2024 - Novugen
Pagari Life Science Corp. Announces the Commercial Launch of Helocaine®, a New Transformative Cold Sore Treatment
Pagari Life Science Corporation is revolutionizing cold sore treatment with the commercial launch of Helocaine®. - May 01, 2024 - Pagari Life Sciences
Revolutionizing Clinical Trials: AnzuBridge Unveils Next-Generation Solutions for Improved Efficacy Evaluations in the Treatment of Rare Disease
AnzuBridge® updates its CDMS to enhance biotech evaluations with advanced video tools, ensuring precise efficacy recording and compliance. It supports scalable trials and features HIPAA-compliant media capture, ePRO for patient engagement, and sophisticated video review capabilities, all integrated with a Learning Management System for efficient trial management. - April 30, 2024 - Anzu
No More Acetone: Thar Process Develops Clean and Green Process to Create Sterile, Fat-Free Lecithin Powder and GMP Quality Oils for Human Consumption
Thar Process, with 34 years of expertise in supercritical fluid extraction, has developed a sustainable way to produce de-fatted lecithin powder that has less oil and longer shelf-life stability. The new process is semi-continuous and sustainable because it utilizes upcycled CO2 from waste sources instead of using toxic acetone which is the industry standard. - April 26, 2024 - Thar Process, LLC
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the European Union. This... - April 25, 2024 - ALPCO
Mirror Biologics, Inc. Appoints Elizabeth Czerepak as Chief Financial Officer and VP Corporate Development
Mirror Biologics, Inc., a clinical stage biopharmaceutical company announces the appointment of Elizabeth Adkins Czerepak as Chief Financial Officer (CFO) and Vice President of Corporate Development effective April 15, 2024. Ms. Czerepak has served as CFO of several biotechnology companies over... - April 18, 2024 - Mirror Biologics, Inc.
I Holland Unveils TSAR 2: Advancing Predictive Modelling in Tablet Compression
I Holland proudly announces the development of TSAR 2, an advanced predictive model developed through a collaborative partnership between academia and industry. Building upon the success of the Tabletting Science Anti-Stick Research (TSAR) project, I Holland continues its groundbreaking research... - April 12, 2024 - I Holland Ltd.
Boiron’s New Arnicare® Wellness Kits Offer Holistic Approach to Pain Management
Boiron, world leader in homeopathic medicines, introduces its new Arnicare Wellness Kits as convenient and comprehensive solutions for painsleep and stress relief. The kits are designed to provide individuals with daytime and nighttime options to manage pain with occasional sleeplessness and... - April 11, 2024 - Boiron
Huntington Study Group Launches Project AWARE 2.0 Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group
Minus K Congratulates to the Winners of Their 2023/2024 Educational Giveaway
Minus K congratulates the four winners of the Minus K's 2023/2024 Educational Giveaway. Over $75,000 of new passive mechanical hub hertz vibration isolators have been granted to universities and colleges in the U.S. over the last ten years. - April 10, 2024 - Minus K Technology Inc.